Overview
Xujun Chu practices in Beijing, China. Chu is rated as an Advanced expert by MediFind in the treatment of Transthyretin Amyloidosis. Their top areas of expertise are Transthyretin Amyloidosis, Primary Amyloidosis, Familial Transthyretin Amyloidosis, and Retinopathy Pigmentary Mental Retardation.
Their clinical research consists of co-authoring 15 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Transthyretin Amyloidosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Transthyretin Amyloidosis
- Experienced
- Cardiac AmyloidosisChu isExperienced. Learn about Cardiac Amyloidosis.
- Congenital Fiber-Type Disproportion
- Familial Transthyretin Amyloidosis
- Limb-Girdle Muscular Dystrophy
- Methylmalonic AcidemiaChu isExperienced. Learn about Methylmalonic Acidemia.
- Mitochondrial Complex 1 Deficiency